Premier Fund Managers LTD Edwards Lifesciences Corp Transaction History

Premier Fund Managers LTD

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	BUY	$72.54 - $95.56 $9.52 Million - $12.5 Million	131,233 New	131,233 $12.5 Million
Q1 2021 May 10, 2021	SELL	$78.68 - $90.67 $6.06 Million - $6.99 Million	-77,040 Closed	0 $0
Q4 2020 Feb 09, 2021	SELL	$71.69 - $91.23 $342,678 - $436,079	-4,780 Reduced 5.84%	77,040 $7.03 Million
Q3 2020 Nov 13, 2020	SELL	$67.19 - $87.44 $3.52 Million - $4.58 Million	-52,370 Reduced 39.03%	81,820 $6.41 Million
Q2 2020 Aug 13, 2020	BUY	$57.54 - $76.95 $7.72 Million - $10.3 Million	134,190 New	134,190 $9.27 Million

1,417

469M

2.44M

2.65M

Ticker EW
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 618,259,968
Market Cap $40.5B
Description
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...

Get notified when there are updates to the investment portfolio of Premier Fund Managers LTD, based on Form 13F filings with the SEC.

Stay updated on Premier Fund Managers LTD with notifications on news.